Zdrowie i gospodarka · 13/03/2015

FDA Extends Comment Period for Combination Products Guidance

The Food and Drug Administration (FDA) is extending the comment period for its draft guidance on combination products until April 29, 2015, in response to a request for an additional 30-day extension to allow industry and FDA staff to submit comments.